![]() |
JOURNAL TOOLS |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |

I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
ORIGINAL ARTICLE
The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 December;64(4):393-9
DOI: 10.23736/S1824-4785.18.03088-1
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
Correlation of 18F-FDG uptake and thyroid cancer stem cells
Ya-Ju HSIEH 1, 2, Tzu-Ying LU 3, Chien-Chih KE 4, 5, Yaoh-Shiang LIN 6, Hsiao-Ting TAI 2, Shiuh-Inn LIU 7, Tsung-Jung LIANG 7, Hsing-Hao SU 6, Ren-Shyan LIU 4, 5, 8, 9, 10, 11, Nan-Jing PENG 12, 13 ✉
1 Department of Medical Imaging and Radiological Sciences, Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; 2 Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; 3 Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; 4 Biomedical Imaging Research Center, National Yang-Ming University, Taipei, Taiwan; 5 Molecular and Genetic Imaging Core, Taiwan Mouse Clinic, National Comprehensive Mouse Phenotyping and Drug Testing Center, Taipei, Taiwan; 6 Department of Otolaryngology Head and Neck, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 7 Division of General Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 8 National PET/Cyclotron Center and Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; 9 Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan; 10 Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; 11 Biophotonic and Molecular Imaging Research Center, National Yang-Ming University, Taipei, Taiwan; 12 National Yang-Ming University School of Medicine, Taipei, Taiwan; 13 Department of Nuclear Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
BACKGROUND: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography (18F-FDG PET) has the potential to detect various types of cancers, including thyroid cancer (TC), at a potentially curable stage. Increased uptake of 18F-FDG was observed in anaplastic and poorly differentiated thyroid cancer cells, and PET-positive tumors are more likely to be resistant to 131I treatment. As cancer stem cells (CSCs) possess a dedifferentiated phenotype and are resistant to many anticancer therapies, we hypothesized that the expression of CSC-related markers is correlated with the ability of tumor cells in TC to uptake FDG.
METHODS: The present study cohort included 12 patients with TC, who underwent 18F-FDG PET/CT imaging before surgery. Quantitative polymerase chain reaction (QPCR) and immunohistochemical (IHC) staining were performed to analyze the expression patterns of gene markers related to embryonic stem (ES) cells and CSCs in TC.
RESULTS: The mRNA expression levels of CSC- (CD133 and CD44) and ES-related genes (Oct4 and Nanog) were higher in TC tissue than in normal thyroid tissue, whereas the mRNA expression levels of thyroid-specific genes (Tg, TSHR, and TTF1) were higher in normal thyroid tissue than in TC tissue. There was a positive and statistically significant correlation between FDG uptake (SUV
CONCLUSIONS: The pre-therapeutic tumor SUV
KEY WORDS: Fluorodeoxyglucose F18; Positron-emission tomography; Thyroid neoplasms; Neoplastic stem cells